Orchestra BioMed Holdings (OBIO) Interest Coverage Ratio (2021 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Interest Coverage Ratio came in at 8.24 in Q1 2026, up 79.88% year-on-year from 4.58 in Q1 2025, and down 144.04% on a QoQ basis from 18.71 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 6 years of Interest Coverage Ratio data on file, last reported at 8.24 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 79.88% year-over-year to 8.24 in Q1 2026; TTM through Mar 2026 was 20.52, a 101.4% decrease from a year earlier, with the FY2025 full-year figure at 0.48, up 30.12% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 8.24, down from 18.71 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for OBIO reached as high as 44.42 in Q4 2023 and fell as low as 90.28 in Q3 2025.
- Historically, Interest Coverage Ratio has averaged 13.33 across 5 years, with a median of 10.49 in 2024.
- Across the five-year window, Interest Coverage Ratio plunged 867.74% in 2022 and jumped 249.59% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 29.69 in 2022, then soared by 249.59% to 44.42 in 2023, then tumbled by 35.15% to 28.8 in 2024, then sank by 35.04% to 18.71 in 2025, then slumped by 144.04% to 8.24 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 8.24 in Q1 2026, 18.71 in Q4 2025, and 90.28 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 | -8.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.24 |
| Dec 31, 2025 | 18.71 |
| Sep 30, 2025 | -90.28 |
| Jun 30, 2025 | -8.62 |
| Mar 31, 2025 | -40.95 |
| Dec 31, 2024 | 28.80 |
| Sep 30, 2024 | -12.77 |
| Jun 30, 2024 | -2.02 |
| Mar 31, 2024 | -10.49 |
| Dec 31, 2023 | 44.42 |
| Sep 30, 2023 | -1.94 |
| Jun 30, 2023 | -3.24 |
| Mar 31, 2023 | -32.89 |
| Dec 31, 2022 | -29.69 |
| Sep 30, 2022 | -26.01 |
| Jun 30, 2022 | -29.70 |
| Mar 31, 2022 | -21.73 |
| Dec 31, 2021 | -3.07 |
| Sep 30, 2021 | -3.15 |
| Jun 30, 2021 | -3.21 |